Stonebridge Capital Advisors LLC
Position in DMAC — DiaMedica Therapeutics Inc.
CIK 1600035
ST PAUL, MN
Position in DMAC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$102,080
-$16,395 QoQ
Shares Held
14,500
-17.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#53
of 87 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $987,042 across 3 Biotechnology names. DMAC ranks #3 (10.3% of the industry book) .
All Filings in DMAC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,080 | 14,500 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $118,475 | 17,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $139,300 | 17,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $120,225 | 17,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $68,250 | 17,500 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $66,325 | 17,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $95,025 | 17,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $73,325 | 17,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $59,000 | 20,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,400 | 20,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $56,800 | 20,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $51,600 | 20,000 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||